Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05022615 · ClinicalTrials.gov registry record

Comparing 3 Imaging Systems

A clinical trial of Diabetic Retinopathy, sponsored by University of Wisconsin, Madison.

Completed
Registry status
51
Enrollment target
1
Study location

NCT05022615 is a study of Diabetic Retinopathy that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 51 participants, below the 1,676-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05022615, a study of Diabetic Retinopathy, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
51 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the quality of ocular images captured on 3 different cameras of patients with diabetic retinopathy. The study will determine whether diabetic retinopathy assessment is comparable between the cameras. The research is being done to see if a camera takes higher quality pictures over the other cameras. 60 participants will be enrolled into this study. Participants need to have diabetic eye disease. This is a one-time study visit that lasts approximately 1 hour.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Topcon Camera
  • DIAGNOSTIC_TEST Optos Camera
  • DIAGNOSTIC_TEST Clarus Camera

Study Locations (1)

Wisconsin

  • UW Health - University Station Clinic - Madison

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2021-09-29
Est. Completion 2023-03-07

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT05022615

The ClinicalTrials.gov registry entry for NCT05022615 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,676-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (97% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 3 interventions - of which Topcon Camera is the first listed.

NCT05022615 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05022615 about?

NCT05022615 is a clinical study titled "Comparing 3 Imaging Systems". The purpose of this study is to evaluate the quality of ocular images captured on 3 different cameras of patients with diabetic retinopathy. The study will determine whether diabetic retinopathy assessment is comparable between the cameras. The research is being done to see if a camera takes higher ...

What is the current status of trial NCT05022615?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2021-09-29. Estimated completion is 2023-03-07.

What conditions does trial NCT05022615 study?

This clinical trial studies the following conditions: Diabetic Retinopathy.

What interventions are being tested in trial NCT05022615?

The interventions under investigation include: Topcon Camera (DIAGNOSTIC_TEST), Optos Camera (DIAGNOSTIC_TEST), Clarus Camera (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05022615?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05022615 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Retinopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.